BeOne Medicines (BEIGF) Interest Coverage Ratio (2015 - 2026)
BeOne Medicines' (BEIGF) quarterly Interest Coverage Ratio came in at 8.18 in Q2 2026, down 25.59% year-over-year from 10.99 in Q2 2025, and up 7.64% quarter-over-quarter from 7.6 in Q1 2026.
Powered by 
Analysis
BeOne Medicines (BEIGF) Interest Coverage Ratio (2015 - 2026) Analysis & Trends
BeOne Medicines (BEIGF) has reported Interest Coverage Ratio for 4 consecutive years, with 8.18 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest Coverage Ratio fell 25.59% year-over-year to 8.18 in Q2 2026; TTM through Jun 2026 was 10.53, a 261.33% increase from a year earlier, with the FY2025 full-year figure at 7.68, up 129.47% from the prior year.
- Interest Coverage Ratio was 8.18 for Q2 2026 at BeOne Medicines, up from 7.6 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 10.99 in Q2 2025 and troughed at 1.59 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.88 Bn | 625.12 Bn | 17.26 Bn | 25.41 |
| 2 | AbbVie | 442.18 Bn | 435.61 Bn | 12.70 Bn | - |
| 3 | Merck | 366.59 Bn | 359.45 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.49 Bn | 258.80 Bn | 11.24 Bn | 10.28 |
| 5 | Pfizer | 159.09 Bn | 147.39 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.34 Bn | 44.96 Bn | 10.79 Bn | 3.65 |
| 7 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -21.24 |
| 8 | Incyte | 25.38 Bn | 20.85 Bn | 1.57 Bn | 1,199.14 |
| 9 | United Therapeutics | 21.53 Bn | 18.87 Bn | 683.80 Mn | 114.07 |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn | 8.18 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.18 |
| Mar 31, 2026 | 7.60 |
| Jun 30, 2025 | 10.99 |
| Mar 31, 2025 | 1.59 |
| Sep 30, 2016 | -122.63 |
| Jun 30, 2016 | -174.67 |
| Mar 31, 2016 | -99.68 |
| Sep 30, 2015 | -46.64 |
| Jun 30, 2015 | -24.05 |
| Mar 31, 2015 | -36.75 |